Differential diagnosis of myotonic disorders

Muscle and Nerve

Volumn 37, Issue 3, 2008, Pages 293-299

  Miller, Timothy M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Myotonia; Myotonia congenita; Myotonic dystrophy; Paramyotonia; Periodic paralysis; Schwartz Jampel syndrome

Indexed keywords

GLUCAN 1,4 ALPHA GLUCOSIDASE;

DIFFERENTIAL DIAGNOSIS; ELECTRODIAGNOSIS; ELECTROMYOGRAM; ENZYME DEFICIENCY; EXERCISE TEST; HUMAN; MUSCLE CONTRACTION; MUSCLE EXCITATION; MUSCLE STIFFNESS; MYOTONIA; MYOTONIC DYSTROPHY; PARAMYOTONIA; PERIODIC PARALYSIS; PRIORITY JOURNAL; REVIEW; SYMPTOM; THOMSEN DISEASE;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MYOTONIC DISORDERS;

EID: 39749130004     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20923     Document Type: Review

References (44)

1. AAEE glossary of terms in clinical electromyography. Muscle Nerve 1987;10:G1-G60.
2. Aminoff MJ. Electrodiagnosis in clinical neurology. New York: Churchill-Livingstone; 1999.
3. Aminoff MJ, Layzer RB, Satya-Murti S, Faden AI. The declining electrical response of muscle to repetitive nerve stimulation in myotonia. Neurology 1977;27:812-816.
4. Astrom KE, Kugelberg E, Muller R. Hypothyroid myopathy. Arch Neurol 1961;5:472-482.
5. Blomberg LH. Dystrophia myotonica probably caused by chloroquine. Acta Neurol Scand Suppl 1965;13(Pt 2):647-651.
6. Bradley WG, Taylor R, Rice DR, Hausmanowa-Petruzewicz I, Adelman LS, Jenkison M, et al. Progressive myopathy in hyperkalemic periodic paralysis. Arch Neurol 1990;47:1013-1017.
7. Brown JC. Muscle weakness after rest in myotonic disorders; an electrophysiological study. J Neurol Neurosurg Psychiatry 1974;37:1336-1342.
8. Brown WF, Bolton CF, Aminoff MJ. Neuromuscular function and disease: basic, clinical, and electrodiagnostic aspects. Philadelphia: WB Saunders; 2002.
9. Caccia MR, Boiardi A, Andreussi L, Cornelio F. Nerve supply and experimental myotonia in rats. J Neurol Sci 1975;24:145-150.
10. Cannon SC. An expanding view for the molecular basis of familial periodic paralysis. Neuromuscul Disord 2002;12:533-543.
11. Cannon SC, Brown RH Jr, Corey DP. A sodium channel defect in hyperkalemic periodic paralysis: potassium-induced failure of inactivalion. Neuron 1991;6:619-626.
12. Colding-Jorgensen E, DunØ M, Schwartz M, Vissing J. Decrement of compound muscle action potential is related to mutation type in myotonia congenita. Muscle Nerve 2003;27: 449-455.
13. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003;60:657-664.
14. Dromgoole SH, Campion DS, Peter JB. Myotonia-induced by clofibrate and sodium chlorophenoxy isobutyrate. Biochem Med 1975;14:238-240.
15. Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice. New York: Oxford University Press; 2001.
16. Kwiecinski H. Myotonia induced with clofibrate in rats. J Neurol 1978;219:107-116.
17. Kwiecinski H, Lehmann-Horn F, Rudel R. Drug-induced myotonia in human intercostal muscle. Muscle Nerve 1988;11: 576-581.
18. Links T, Zwarts MJ, Wilmink JT, Molenaar WM, Oosterhuis HJ. Permanent muscle weakness in familial hypokalaemic periodic paralysis. Clinical, radiological and pathological aspects. Brain 1990;113:1873-1889.
19. Links TP, Smit AJ, Molenaar WM, Zwarts MJ, Oosterhuis Hf. Familial hypokalemic periodic paralysis. Clinical, diagnostic and therapeutic aspects. J Neurol Sci 1994;122:33-43.
20. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001;293:864-867.
21. Logigian EL, Ciafaloni E, Quinn LC, Dilek N, Pandya S, Moxley RT 3rd, et al. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy. Muscle Nerve 2007;35:479-485.
22. Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve 2005;32:1-18.
23. Mathieu J, Allard P, Potvin L, Prevost C, Begin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999;52:1658-1662.
24. McManis PG, Lambert EH, Daube JR. The exercise test in periodic paralysis. Muscle Nerve 1986;9:704-710.
25. Miller TM, Dias da Silva MR, Miller HA, Kwiecinski H, Mendell JR, Tawil R, et al. Correlating phenotypc and genotype in the periodic paralyses. Neurology 2004;63:1647-1655.
26. Nicole S, Davoine CS, Topaloglu H, Cattolico L, Barral D, Beighton P, et al. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet 2000; 26:480-483.
27. Nicole S, Topaloglu H, Fontaine B. 102nd ENMC International Workshop on Schwartz-Jampel syndrome, 14-16 December, 2001, Naarden, The Netherlands. Neuromuscul Disord 2003;13:347-351.
28. Nielsen VK, Friis ML, Johnsen T. Electromyographic distinction between paramyotonia congenita and myotonia congenita: effect of cold. Neurology 1982;32:827-832.
29. Pierno S, De Luca A, Tricarico D, Roselli A, Natuzzi F, Ferrannini E, et al. Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers. J Pharmacol Exp Ther 1995;275:1490-1496.
30. Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001;105:511-519.
31. Pourmand R. Neuromuscular diseases: expert clinicians' views. Boston: Butterworth-Heinemann; 2001.
32. Ptacek LJ, Tawil R, Griggs RC, Storvick D, Leppert M. Linkage of atypical myotonia congenita to a sodium channel locus. Neurology 1992;42:431-433.
33. Ramsey RB, McGarry JD, Fischer VW, Sarnat HB. Alteration of developing and adult rat muscle membranes by zuclomiphene and other hypocholesterolemic agents. Acta Neuropathol (Berl) 1978;44:15-19.
34. Renner DR, Ptacek LJ. Periodic paralyses and nondystrophic myotonias. Adv Neurol 2002;88:235-252.
35. Ricker K, Hertel G, Langscheid K, Stodieck G. Myotonia not aggravated by cooling. Force and relaxation of the adductor pollicis in normal subjects and in myotonia as compared to paramyotonia. J Neurol 1977;216:9-20.
36. Ricker K, Koch MC, Lehmann-Hom F, Pongratz D, Otto M, Heine R, et al. Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 1994;44:1448-1452.
37. Rosenson RS. Current overview of statin-induced myopathy. Am J Med 2004;116:408-416.
38. Rutkove SB, De Girolami U, Preston DC, Freeman R, Nardin RA, Gouras GK, et al. Myotonia in colchicine myoneuropathy. Muscle Nerve 1996;19:870-875.
39. Sander HW, Scelsa SN, Conigliari MF, Chokroverty S. The short exercise test is normal in proximal myotonic myopathy. Clin Neurophysiol 2000;111:362-366.
40. Scarpalezos S, Lygidakis C, Papageorgiou C, Maliara S, Koukoulommati AS, Koutras DA. Neural and muscular manifestations of hypothyroidism. Arch Neurol 1973;29: 140-144.
41. Sonoda Y, Gotow T, Kuriyama M, Nakahara K, Arimura K, Osame M. Electrical myotonia of rabbit skeletal muscles by HMG-CoA reductase inhibitors. Muscle Nerve 1994;17:891-897.
42. Streib EW. Evoked response testing in myotonic syndromes. Muscle Nerve 1984;7:590-592.
43. Stum M, Davoine CS, Vicart S, Guillot-Noel L, Topaloglu H, Carod-Artal FJ, et al. Spectrum of HSPG2 (Perlecan) mutations in patients with Schwartz-Jampel syndrome. Hum Mutat 2006;27:1082-1091.
44. Venables GS, Bates D, Shaw DA. Hypothyroidism with true myotonia. J Neurol Neurosurg Psychiatry 1978;41:1013-1015.